Medtronic Reports Second Quarter Financial Results
- Revenue of $7.5 Billion Increased 6.1% Reported; Increased 7.5% Organic
- GAAP Diluted EPS of $0.82; Non-GAAP Diluted EPS of $1.22
- Cash Flow from Operations of $2.9 Billion in First Six Months vs. $1.6 Billion in Prior Year; Free Cash Flow of $2.4 Billion in First Six Months vs. $1.1 Billion in Prior Year
- Company Increases FY19 Organic Revenue Growth Guidance
DUBLIN - November 20, 2018 - Medtronic plc (NYSE: MDT) today announced financial results for its second quar...